share_log
Moomoo 24/7 ·  Apr 11 07:25
Arvinas Shares Are Trading Higher After the Company Entered a License Agreement With Novartis for the Development and Commercialization of ARV-766 in Prostate Cancer Treatment
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment